Engineered Salmonella enterica serovar Typhimurium overcomes limitations of anti-bacterial immunity in bacteria-mediated tumor therapy

S Felgner, D Kocijancic, M Frahm, U Heise… - …, 2018 - Taylor & Francis
Cancer is one of the leading causes of death in the industrialized world and represents a
tremendous social and economic burden. As conventional therapies fail to provide a …

Use of Salmonella Bacteria in Cancer Therapy: Direct, Drug Delivery and Combination Approaches

F Badie, M Ghandali, SA Tabatabaei, M Safari… - Frontiers in …, 2021 - frontiersin.org
Over the years, conventional cancer treatments, such as chemotherapy with only a limited
specificity for tumors, have undergone significant improvement. Moreover, newer therapies …

Targeted cancer immunotherapy with genetically engineered oncolytic Salmonella typhimurium

Y Guo, Y Chen, X Liu, JJ Min, W Tan, JH Zheng - Cancer letters, 2020 - Elsevier
Conventional chemotherapies have some limitations, including the lack of selectivity, high
toxicity to normal tissues, multidrug resistance, and tumor relapse. Recently, great progress …

[HTML][HTML] Local application of bacteria improves safety of Salmonella-mediated tumor therapy and retains advantages of systemic infection

D Kocijancic, S Felgner, T Schauer, M Frahm, U Heise… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Cancer is a devastating disease and a large socio-economic burden. Novel therapeutic
solutions are on the rise, although a cure remains elusive. Application of microorganisms …

Optimizing Salmonella enterica serovar Typhimurium for bacteria-mediated tumor therapy

S Felgner, D Kocijancic, M Frahm, R Curtiss III… - Gut …, 2016 - Taylor & Francis
Bacteria-mediated tumor therapy using Salmonella enterica serovar Typhimurium is a
therapeutic option with great potential. Numerous studies explored the potential of …

[PDF][PDF] Therapeutic vaccines based on genetically modified Salmonella: a novel strategy in cancer immunotherapy

P Chorobik, J Marcinkiewicz - 2011 - ruj.uj.edu.pl
In the course of evolution, bacteria from the genus Salmonella adapted to survive and
multiply in a ver‑tebrate host. Skillful use of bacterial inter actions with the host immune …

[HTML][HTML] Therapeutic benefit of Salmonella attributed to LPS and TNF-α is exhaustible and dictated by tumor susceptibility

D Kocijancic, S Leschner, S Felgner, RM Komoll… - Oncotarget, 2017 - ncbi.nlm.nih.gov
The potential of bacteria-mediated tumor therapy (BMTT) is highlighted by more than a
century of investigation. Attenuated Salmonella has prevailed as promising therapeutic …

Targeted cancer therapy using engineered Salmonella typhimurium

JH Zheng, JJ Min - Chonnam medical journal, 2016 - synapse.koreamed.org
Obligate or facultative anaerobic bacteria such as Bifidobacterium, Clostridium, Salmonella,
or Escherichia coli specifically colonize and proliferate inside tumor tissues and inhibit tumor …

[HTML][HTML] Salmonella-mediated cancer therapy: an innovative therapeutic strategy

Z Mi, ZC Feng, C Li, X Yang, MT Ma, PF Rong - Journal of Cancer, 2019 - ncbi.nlm.nih.gov
Bacterial-mediated cancer therapy (BMCT) has become a hot topic in the area of antitumor
treatment. Salmonella has been recommended to specifically colonize and proliferate inside …

Cancer Immunotherapy: Priming the Host Immune Response with Live Attenuated Salmonella enterica

MA Hernández-Luna… - Journal of Immunology …, 2018 - Wiley Online Library
In recent years, cancer immunotherapy has undergone great advances because of our
understanding of the immune response and the mechanisms through which tumor cells …